title: Overview consensus statement.
authors.affiliation: Department of Urology, University of California School of Medicine, San Francisco, California, USA. Pcarroll@urol.ucsf.edu
authors.forename: P R
authors.initials: PR
authors.lastname: Carroll
authors.forename: W R
authors.initials: WR
authors.lastname: Fair
authors.forename: G D
authors.initials: GD
authors.lastname: Grossfeld
authors.forename: W D
authors.initials: WD
authors.lastname: Heston
authors.forename: R
authors.initials: R
authors.lastname: Lieberman
authors.forename: S B
authors.initials: SB
authors.lastname: Malkowicz
authors.forename: H J
authors.initials: HJ
authors.lastname: Stricker
authors.forename: J
authors.initials: J
authors.lastname: Sylvester
authors.forename: D M
authors.initials: DM
authors.lastname: Peehl
authors.forename: F
authors.initials: F
authors.lastname: Meyer
authors.forename: C
authors.initials: C
authors.lastname: Hart
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003245:Consensus Statements as Topic; D004334:Drug Administration Schedule; D007987:Gonadotropin-Releasing Hormone / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone